Presentation is loading. Please wait.

Presentation is loading. Please wait.

Care of Patients with Arthritis and Other Connective Tissue Diseases

Similar presentations


Presentation on theme: "Care of Patients with Arthritis and Other Connective Tissue Diseases"— Presentation transcript:

1 Care of Patients with Arthritis and Other Connective Tissue Diseases
Chapter 20 Care of Patients with Arthritis and Other Connective Tissue Diseases

2 Rheumatology Connective tissue disease (CTD) is a major focus of rheumatology. Rheumatic disease is any disease or condition involving the musculoskeletal system. Arthritis means inflammation of one or more joints.

3 Rheumatology (Cont’d)
Noninflammatory arthritis (osteoarthritis) is not systemic. OA is not an autoimmune disease. Inflammatory arthritis: Rheumatoid arthritis Systemic lupus erythematosus Autoimmune disease Connective tissue disease that is inflammatory

4 Osteoarthritis Most common type of arthritis
Joint pain and loss of function characterized by progressive deterioration and loss of cartilage in the joints Osteophytes Synovitis Subluxation

5 Joint Changes in Degenerative Joint Disease

6 Collaborative Management
History Physical assessment and clinical manifestations: Joint involvement Heberden's nodes Bouchard’s nodes Joint effusions Atrophy of skeletal muscle

7 Heberden’s Nodes

8 Ballottement

9 Assessments Psychosocial
Laboratory assessment of erythrocyte sedimentation rate and C-reactive protein (may be slightly elevated) Radiographic assessment Other diagnostic assessments: MR imaging CT studies

10 Chronic Pain: Nonsurgical Management
Analgesics Rest Positioning Thermal modalities Weight control Integrative therapies

11 Chronic Pain: Surgical Management
Total joint arthroplasty (TJA) Total joint replacement (TJR) Arthroscopy Osteotomy

12 Total Hip Arthroplasty
Preoperative care Operative procedures Postoperative care: Prevention of dislocation, infection, and thromboembolic complications Assessment of bleeding Management of anemia

13 Hip Flexion After Total Hip Replacement

14 Prevention of Complications
Assessment for neurovascular compromise Management of pain Progression of activity Promotion of self-care

15 Total Knee Arthroplasty
Preoperative care Operative procedures Postoperative care: Continuous passive motion machine Hot/ice device Pain management Neurovascular assessment

16 Continuous Passive Motion Machine

17 Rheumatoid Arthritis One of the most common connective tissue diseases and the most destructive to the joints Chronic, progressive, systemic inflammatory autoimmune disease affecting primarily the synovial joints Autoantibodies (rheumatoid factors) formed that attack healthy tissue, especially synovium, causing inflammation Affects synovial tissue of any organ or body system

18 RA Pathology

19 RA—Collaborative Management
Assessment Physical assessment and clinical manifestations: Early disease manifestations—joint stiffness, swelling, pain, fatigue, and generalized weakness and morning stiffness Late disease manifestations—as the disease worsens, the joints become progressively inflamed and quite painful

20 RA Joint Involvement

21 RA Systemic Complications
Weight loss, fever, and extreme fatigue Exacerbations Subcutaneous nodules Pulmonary complications Vasculitis Periungual lesions Paresthesias Cardiac complications

22 RA—Assessments Psychosocial assessment
Laboratory assessment—rheumatoid factor, antinuclear antibody titer, erythrocyte sedimentation rate, serum complement, serum protein electrophoresis, serum immunoglobulins Other diagnostic assessments—x-ray, CT, arthrocentesis, bone scan

23 RA—Drug Therapy Disease-modifying antirheumatic drugs NSAIDs
Biologic response modifiers Other drugs: Glucocorticoids Immunosuppressive agents Gold therapy Analgesic drugs

24 RA—Nonpharmacologic Interventions
Adequate rest Proper positioning Ice and heat applications Plasmapheresis Gene therapy Complementary and alternative therapies Promotion of self-care

25 RA—Nonpharmacologic Interventions (Cont’d)
Management of fatigue Enhancement of body image Community-based care: Home care management Health teaching Health care resources

26 Lupus Erythematosus Chronic, progressive, inflammatory connective tissue disorder that can cause major body organs and systems to fail. Characterized by spontaneous remissions and exacerbations. Autoimmune process. Autoimmune complexes tend to be attracted to the glomeruli of the kidneys. Many patients with SLE have some degree of kidney involvement.

27 Lupus Erythematosus—Clinical Manifestations
Skin involvement Polyarthritis Osteonecrosis Muscle atrophy Fever and fatigue

28 Characteristic “Butterfly” Rash of Systemic Lupus Erythematosus

29 LE—Clinical Manifestations
Renal involvement Pleural effusions Pericarditis Raynaud’s phenomenon Neurologic manifestation Serositis

30 Assessments for Lupus Psychosocial results can be devastating.
Laboratory: Skin biopsy (only significant test to confirm diagnosis) Immunologic-based laboratory tests Complete blood count Body system function assessment

31 SLE—Drug Therapy Topical drugs Plaquenil Tylenol or NSAIDs
Chronic steroid therapy Immunosuppressive agents

32 Scleroderma (Systemic Sclerosis)
Chronic, inflammatory, autoimmune connective tissue disease Not always progressive Hardening of the skin

33 Scleroderma

34 CREST Syndrome C—calcinosis R—Raynaud’s phenomenon
E—esophageal dysmotility S—sclerodactyly T—telangiectasia

35 Scleroderma—Clinical Manifestations
Arthralgia GI tract Cardiovascular system Pulmonary system Renal system

36 Scleroderma—Interventions
Drug therapy Identify early organ involvement Skin protective measures Comfort GI manifestation Mobility

37 Gout Also called gouty arthritis, a systemic disease in which urate crystals deposit in the joints and other body tissues, causing inflammation Primary gout Secondary gout—hyperuricemia

38 Gout—Interventions Drug therapy Nutritional therapy

39 Other Connective Tissue Diseases
Polymyositis Systemic necrotizing vasculitis Polymyalgia rheumatica and temporal arteritis Ankylosing spondylitis Reiter’s syndrome Marfan syndrome Infectious arthritis

40 Lyme Disease Reportable systemic infectious disease caused by the spirochete Borrelia burgdorferi, resulting from the bite of an infected deer tick. Stages I and II. If not diagnosed and treated in early stages, chronic complications such as arthralgias, fatigue, and memory and thinking problems can result. For some patients, the first and only sign of Lyme disease is arthritis.

41 Lyme Disease Rash

42 Fibromyalgia Syndrome
Chronic pain syndrome, not an inflammatory disease

43 Chronic Fatigue Syndromes
Chronic illness in which patients have severe fatigue for 6 months or longer, usually following flu-like symptoms Sore throat; substantial impairment in short-term memory or concentration; tender lymph nodes; muscle pain; multiple joint pain with redness or swelling; headaches of a new type, pattern, or severity; unrefreshing sleep; and postexertional malaise lasting more than 24 hours

44 Chapter 22 Care of Patients with Immune Function Excess: Hypersensitivity (Allergy) and Autoimmunity

45 Hypersensitivities/Allergies
Increased or excessive response to the presence of an antigen to which the patient has been exposed Degree of reaction ranging from uncomfortable to life threatening Sentences and phrases

46 Type I: Rapid Hypersensitivity Reactions
Also called atopic allergy, this is the most common type of hypersensitivity. Some reactions occur just in the areas exposed to the antigen.

47 Type I: Rapid Hypersensitivity Reactions (Cont’d)
Allergens can be contacted in these ways: Inhaled (plant pollens, fungal spores, animal dander, house dust, grass, ragweed) Ingested (foods, food additives, drugs) Injected (bee venom, drugs, biologic substances)

48 Type I: Rapid Hypersensitivity Reactions (Cont’d)
Contacted (pollens, foods, environmental proteins) Other reactions may involve all blood vessels and bronchiolar smooth muscle, causing widespread blood vessel dilation, decreased cardiac output, and bronchoconstriction, which is known as anaphylaxis

49 Allergic Rhinitis

50 Patient-Centered Collaborative Care
History Laboratory assessment—increased eosinophils, immunoglobulin E (IgE), RAST Allergy testing Patient preparation Procedure Follow-up care Oral food challenges

51 Interventions Avoidance therapy: Environmental changes:
Air-conditioning and air-cleaning units Cloth drapes Upholstered furniture Carpeting Pet-induced allergies

52 Drug Therapy Decongestants Antihistamines Corticosteroids
Mast cell stabilizers Leukotriene antagonists Complementary and alternative therapy Desensitization therapy

53 Anaphylaxis First feelings of uneasiness, apprehension, weakness, and impending doom. Pruritus and urticaria. Erythema and sometimes angioedema of the eyes, lips, or tongue.

54 Anaphylaxis (Cont’d) Histamine causes capillary leak, bronchoconstriction, mucosal edema, and excess mucus secretion. Congestion, rhinorrhea, dyspnea, and increasing respiratory distress with audible wheezing result. Anaphylaxis can be fatal.

55 Interventions First assess respiratory function; an airway must be established. CPR may be needed. Epinephrine (1:1000) 0.3 to 0.5 mL subcutaneous is given as soon as symptoms appear. Antihistamines treat angioedema and urticaria. Oxygen. Treat bronchospasm. IV fluids.

56 Type II: Cytotoxic Reactions
The body makes special autoantibodies directed against self cells that have some form of foreign protein attached to them. Clinical examples include hemolytic anemias, thrombocytopenic purpura, hemolytic transfusion reactions, Goodpasture’s syndrome, and drug-induced hemolytic anemia.

57 Antibody-Antigen Complexes

58 Type III: Immune Complex Reactions
Excess antigens cause immune complexes to form in the blood. These circulating complexes usually lodge in small blood vessels. Usual sites include the kidneys, skin, joints, and small blood vessels.

59 Type III: Immune Complex Reactions (Cont’d)
Deposited complexes trigger inflammation, resulting in tissue or vessel damage. Rheumatoid arthritis, systemic lupus erythematosus, and serum sickness occur.

60 Immune Complex in a Type III Hypersensitivity Reaction

61 Type IV: Delayed Hypersensitivity Reactions
In a type IV reaction, the reactive cell is the T-lymphocyte (T-cell). Antibodies and complement are not involved. Local collection of lymphocytes and macrophages causes edema, induration, ischemia, and tissue damage at the site.

62 Type IV: Delayed Hypersensitivity Reactions (Cont’d)
Other examples include positive purified protein derivative, contact dermatitis, poison ivy skin rashes, insect stings, tissue transplant rejection, and sarcoidosis.

63 Type V: Stimulatory Reaction
Excess stimulation of a normal cell surface receptor by an autoantibody, resulting in a continuous “turned-on” state for the cell. Graves’ disease.

64 Autoimmunity Autoimmunity is the process whereby a person develops an inappropriate immune response. Antibodies and/or lymphocytes are directed against healthy normal cells and tissues. For unknown reasons, the immune system fails to recognize certain body cells or tissues as self and triggers immune reactions. Sentences and phrases

65 Sjögren’s Syndrome Group of problems that often appear with other autoimmune disorders Dry eyes, dry mucous membranes of the nose and mouth (xerostomia), and vaginal dryness Insufficient tears causing inflammation and ulceration of the cornea No cure; intensity and progression can be slowed by suppressing immune and inflammatory responses

66 Goodpasture’s Syndrome
Autoimmune disorder in which autoantibodies are made against the glomerular basement membrane and neutrophils Lungs and kidneys Shortness of breath, hemoptysis, decreased urine output, weight gain, edema, hypertension, and tachycardia Treatment—high-dose corticosteroids


Download ppt "Care of Patients with Arthritis and Other Connective Tissue Diseases"

Similar presentations


Ads by Google